Leucine — Stack & Timing
Educational timing and stacking information based on how Leucine has been studied. Not a prescription. Not medical advice.
This is educational information only. Consult a healthcare provider before starting any supplement.
Stack & Timing Guidance
Educational summary based on how Leucine has been studied and commonly used.
Commonly studied timing
Research and expert consensus support leucine intake around resistance exercise (pre- or post-workout) to maximize muscle protein synthesis; co-ingestion with protein-containing meals is also supported to enhance anabolic signaling, as leucine requires co-availability of other amino acids to sustain MPS.
Dose ranges used in studies
Studies on sarcopenia and muscle protein synthesis most commonly investigate leucine doses between 2.5 g and 4 g per serving, often delivered within whey protein formulations enriched with leucine; some expert commentary (e.g., Hyman) suggests 2.5 g alone may be subthreshold for optimal effect.
↑ These are ranges from research studies, not personal dosing recommendations. Discuss with a clinician.
Commonly paired with
Whey provides a full essential amino acid profile that works synergistically with leucine to sustain muscle protein synthesis beyond the initial leucine-triggered spike
Vitamin D supports muscle function and neuromuscular signaling; combined with leucine and whey protein it is a common evidence-based trio for sarcopenia management
HMB is a metabolite of leucine and may independently attenuate muscle protein breakdown, complementing leucine's role in stimulating synthesis
Leucine is the primary anabolic driver among BCAAs; isoleucine and valine are often co-supplemented to provide a complete BCAA profile and avoid amino acid imbalances
Safety & interactions
Leucine at doses studied (2.5–4 g per serving) is generally considered safe for healthy adults and older individuals; chronically excessive intake of isolated leucine without balanced amino acid intake may theoretically create amino acid imbalances, and individuals with maple syrup urine disease (MSUD) or impaired branched-chain amino acid metabolism should avoid supplementation.
- •May interact with insulin signaling pathways — individuals with diabetes or on glucose-lowering medications should monitor blood sugar responses
- •High isolated BCAA/leucine intake may compete with tryptophan and other large neutral amino acids for blood-brain barrier transport, potentially affecting serotonin synthesis with very high chronic doses
Individuals with maple syrup urine disease (MSUD) or other inherited disorders of branched-chain amino acid metabolism must avoid leucine supplementation; caution is warranted in those with significant renal impairment, as high protein and amino acid loads may stress compromised kidneys. Pregnant or breastfeeding individuals should consult a healthcare provider before use.